Agomab Therapeutics Selected as One of Fierce Biotech's
Home News Agomab Therapeutics Selected as One of Fierce Biotech's "Fierce 15" Companies of 2022 - #BHHMembersInitiatives

Agomab Therapeutics Selected as One of Fierce Biotech's "Fierce 15" Companies of 2022 - #BHHMembersInitiatives

SEPTEMBER 23, 2022 BHH News

Agomab Therapeutics NV (‘Agomab’) announced that Fierce Biotech has named the company as one of 2022’s Fierce 15 biotechnology companies, designating it as one of the most promising early-stage biotechnology companies in the industry. BHH Member Agomab is a Belgian-headquartered biotech company developing a portfolio of unique small molecule compounds and antibodies that address the transforming growth factor beta (TGF-ß) and hepatocyte growth factor (HGF) pathways.

Growth factor pathways play an important role in morphogenesis and tissue repair and are promising targets for addressing tissue injury and fibrotic remodeling in a range of high unmet medical need indications including fibrostenotic Crohn’s disease and idiopathic pulmonary fibrosis.

“The Fierce 15 award is a great endorsement of our team’s groundbreaking work and we are thrilled to join an outstanding group of companies that Fierce sees as the up-and-coming vanguard for our industry. This important recognition comes in a transformative year in which we have extended a major financing round, acquired another biotech company and successfully conducted a first-in-human study with our lead compound,” said Tim Knotnerus, Chief Executive Officer at Agomab Therapeutics.

“We are developing a range of highly-innovative product candidates that address well-validated and potentially disease-modifying targets while overcoming the challenges of earlier attempts to target growth factors in fibrosis.” The Fierce 15 celebrates the spirit of being “fierce” – championing innovation and creativity, even in the face of intense competition.

This is Fierce Biotech’s 20th annual Fierce 15 selection. An internationally recognized daily report reaching a network of over 450,000 biotech and pharma industry professionals, Fierce Biotech provides subscribers with an authoritative analysis of the day's top stories.

Every year Fierce Biotech evaluates hundreds of early-stage companies from around the world for its annual Fierce 15 list, which is based on a variety of factors such as the strength of its technology, partnerships, venture backers and a competitive market position.

January 29, 2025 BHH News
The Terrassa Health Consortium joins Barcelona Health Hub
The agreement was signed through the Fundació Joan Costa Roma (FJCR), an entity that promotes, develops, coordinates, manages and disseminates research and innovation activities carried out at the CST.
Read more
January 23, 2025 BHH News
Germans Trias i Pujol University Hospital, Germans Trias i Pujol Research Institute, and Digital Health Hub collaborate to boost innovation transfer in the healthcare sector
The agreement aims to benefit from the synergies between the three entities to create a solid collaboration framework.
Read more
January 14, 2025 BHH News
Join Spain’s AI Sandbox Initiative
The sandbox underscores Spain's commitment to becoming a leader in AI innovation, offering its ecosystem the tools and resources needed to address key societal and economic challenges responsibly.
Read more
January 09, 2025 BHH News
Future4Care & BHH partner up to drive digital health innovation from Paris, Berlin and Barcelona
This alliance marks a significant step forward in advancing healthcare systems, fostering collaboration between Paris, Berlin and Barcelona.
Read more
January 03, 2025 BHH News
Join the next donor marathon and help save lives!
This collaborative effort aims to strengthen blood reserves and raise awareness about the critical need for regular blood donations.
Read more
December 19, 2024 BHH News
#BHHInterview with Barcelona Activa
Barcelona Health Hub got together with Sara Díaz of BHH partner Barcelona Activa! BHH's Eva Rosell seized the opportunity to ask about their work.
Read more
December 05, 2024 BHH News
The Impact4kids Acceleration Programme has launched
If you are working on disruptive technological solutions this is your opportunity to gain expert guidance and access to a global network of innovators, researchers, and mentors.
Read more
December 04, 2024 BHH News
Barcelona Health Hub explores innovation with Més Sant Pau Office
Barcelona Health Hub recently had the pleasure of connecting with BHH member Hospital de la Santa Creu i Sant Pau.
Read more
November 27, 2024 BHH News
Madrid Health Hub opens its doors in January 2025!
Madrid Health Hub's mission is to promote innovation in digital health and its transfer to hospitals.
Read more
November 25, 2024 BHH News
Docline's virtual hospital achieves a 30% cost reduction in the insurance industry
Barcelona Health Hub had the pleasure to meet up with Omar Najid, CEO & Founder of Docline.
Read more